Research and Markets: Fibromyalgia - Pipeline Review, H1 2013

Tue Apr 23, 2013 7:17am EDT

* Reuters is not responsible for the content in this press release.

Research and Markets: Fibromyalgia - Pipeline Review, H1 2013

Research and Markets has announced the addition of the "Fibromyalgia - Pipeline Review, H1 2013" report to their offering.

Global Markets Direct's, 'Fibromyalgia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Fibromyalgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fibromyalgia.


- A snapshot of the global therapeutic scenario for Fibromyalgia.

- A review of the Fibromyalgia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Fibromyalgia pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Involved in Fibromyalgia Therapeutics Development

  • Adeona Pharmaceuticals, Inc.
  • Chelsea Therapeutics, Inc.
  • Collegium Pharmaceutical, Inc.
  • Concert Pharmaceuticals, Inc.
  • Dainippon Sumitomo Pharma Co., Ltd.
  • e-Therapeutics plc
  • Intellipharmaceutics International Inc.
  • Jazz Pharmaceuticals, Inc.
  • Meiji Holdings Co., Ltd.
  • Pfizer Inc.
  • SWITCH Biotech LLC
  • Theravance, Inc.

Drug Profiles

  • droxidopa
  • sodium oxybate
  • flupirtine maleate
  • Neurotropin
  • ETS-6218
  • droxidopa + [carbidopa]
  • SWT-06101
  • fluoxetine
  • mirtazapine
  • TD-9855
  • cyclobenzaprine hydrochloride
  • THA-902

For more information visit Research and Markets

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System